2-[(4aR,4bS,6aS,6bS,8R,9aR,10aS,10bS)-8-Cyclohexyl-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-6b-yl]-2-oxoethyl 2-meth ylpropanoate(CAS: 126544-47-6)
![2-[(4aR,4bS,6aS,6bS,8R,9aR,10aS,10bS)-8-Cyclohexyl-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-6b-yl]-2-oxoethyl 2-meth
ylpropanoate 2-[(4aR,4bS,6aS,6bS,8R,9aR,10aS,10bS)-8-Cyclohexyl-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-6b-yl]-2-oxoethyl 2-meth
ylpropanoate](https://cnstatic.chemtradehub.com/structs/126/126544-47-6-bc8f.webp)
CAS号
相关产品
其他供应商提供的 2-[(4aR,4bS,6aS,6bS,8R,9aR,10aS,10bS)-8-Cyclohexyl-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-6b-yl]-2-oxoethyl 2-meth ylpropanoate
基本信息
分子式
C32H44O7
分子量
540.7 g/mol
Physical Properties
熔点
206-213°C
沸点
665°C at 760 mmHg
化学标识符
SMILES
CC(C)C(=O)OCC(=O)[C@]12O[C@@H](O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@@]31C)C6CCCCC6
InChIKey
LUKZNWIVRBCLON-GXOBDPJESA-N
数据库引用
MDL号
MFCD00866004
常见问题
环索奈德是一种化学物质,其英文名称为2-[(4aR,4bS,6aS,6bS,8R,9aR,10aS,10bS)-8-Cyclohexyl-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-6b-yl]-2-oxoethyl 2-methylpropanoate,CAS号为126544-47-6。环索奈德是一种1,4-二氢-2H-3,1-benzoxazin-2-one衍生物,主要用于治疗哮喘和过敏性鼻炎等疾病。
环索奈德主要用于治疗哮喘和过敏性鼻炎等疾病。它具有强大的抗炎作用和免疫调节作用,能够有效缓解哮喘症状和减少鼻炎发作。此外,环索奈德还被用于研究以探索其在其他疾病中的潜在应用。
环索奈德在临床应用中被认为是相对安全的,但使用时仍需注意一些安全事项。使用过程中可能会出现一些副作用,如头痛、鼻塞、喉咙痛、声音嘶哑等。对于某些患者,可能会出现更严重的反应,如过敏反应。因此,在使用时应遵循医生的指导,避免接触眼睛、口腔和其他敏感部位,并注意个人防护措施。
环索奈德应储存在阴凉、干燥、通风良好的地方,避免直接暴露在阳光下。储存温度应控制在室温范围内,避免过高或过低的温度,以防药品变质。储存时应使用密封容器,远离火源和热源。此外,储存过程中应避免与其他有毒或易燃物质接触,以确保安全。
安全须知
使用前请验证产品规格和安全数据。联系供应商获取详细安全信息。
请始终遵循正确的操作程序
联系信息
邮箱
2850183207@qq.com

![6,9-Bis[(2-aminoethyl)amino]benzo[g]isoquinoline-5,10-dione](https://cnstatic.chemtradehub.com/structs/144/144510-96-3-0dd2.webp)

![4-Amino-5-chloro-N-[1-(3-methoxypropyl)-4-piperidinyl]-2,3-dihydro-1-benzofuran-7-carboxamide](https://cnstatic.chemtradehub.com/structs/179/179474-81-8-544a.webp)
![N-{(2S)-2-[(4-Morpholinylacetyl)amino]-4-phenylbutanoyl}-L-leucyl-N-{(2S)-4-methyl-1-[(2R)-2-methyl-2-oxiranyl]-1-oxo-2-pentanyl}-L-phenylalaninamide](https://cnstatic.chemtradehub.com/structs/868/868540-17-4-ac55.webp)
![4-Amino-N-[1-(3-cyclohexen-1-ylmethyl)-4-piperidinyl]-2-ethoxy-5-nitrobenzamide](https://cnstatic.chemtradehub.com/structs/665/66564-14-5-2af4.webp)
![4-[4-({[4-Chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methyl-2-pyridinecarboxamide](https://cnstatic.chemtradehub.com/structs/755/755037-03-7-d9bc.webp)
![3-[(4-Amino-2-methyl-5-pyrimidinyl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium chloride hydrochloride (1:1:1)](https://cnstatic.chemtradehub.com/structs/67-/67-03-8-5020.webp)
![{(5Z)-5-[(2E)-2-Methyl-3-phenyl-2-propen-1-ylidene]-4-oxo-2-thioxo-1,3-thiazolidin-3-yl}acetic acid](https://cnstatic.chemtradehub.com/structs/821/82159-09-9-5291.webp)